Vericel Corporation
NASDAQ: VCEL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dominick C. Colangelo
- Employees
- 357
- Headquarters
- Cambridge, United States
- IPO year
- 1997
- Market cap
- $2.1B
- Website
- https://vcel.com
Loading VCEL…
Loading profile data…Frequently asked questions about VCEL
What does Vericel Corporation (VCEL) do?
Vericel Corporation operates as a biopharmaceutical firm that has reached the commercialization phase, specializing in the research, development, production, and distribution of cell-based treatments. Its primary therapeutic areas are sports medicine and critical burn care across the United States. The company's product lineup includes MACI, an...
Where does VCEL trade?
Vericel Corporation (VCEL) trades on the NASDAQ Capital Market.
What sector is VCEL in?
Vericel Corporation (VCEL) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Vericel Corporation?
Dominick C. Colangelo is the chief executive officer of Vericel Corporation (VCEL).
Where is Vericel Corporation headquartered?
Vericel Corporation is headquartered in United States.
Does VCEL pay a dividend?
Vericel Corporation (VCEL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VCEL go public?
Vericel Corporation (VCEL) completed its initial public offering in 1997.